Quick Answer
COGNITION THERAPEUTICS INC reported Cash and Equivalents of $36.81 million for fiscal year 2025.
COGNITION THERAPEUTICS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $36.81M | +47.2% |
| 2024 | $25.01M | -16.4% |
| 2023 | $29.92M | -28.0% |
| 2022 | $41.56M | -24.0% |
| 2021 | $54.72M | +954.6% |
| 2020 | $5.19M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $39.33M | +78.7% | +266.1% |
| June 30, 2025 | $10.74M | -62.3% | -34.6% |
| March 31, 2025 | $16.43M | -52.6% | -34.3% |
| December 31, 2024 | $25.01M | -16.4% | +13.6% |
| September 30, 2024 | $22.01M | -33.2% | -22.9% |
| June 30, 2024 | $28.53M | -23.3% | -17.7% |
| March 31, 2024 | $34.67M | -10.7% | +15.9% |
| December 31, 2023 | $29.92M | -28.0% | -9.2% |
- COGNITION THERAPEUTICS INC showed an increase of +47.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, COGNITION THERAPEUTICS INC’s cash and equivalents has grown by 609.4% (from $5.19 million to $36.81 million).
- The most recent figure is from COGNITION THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: